Amyloid β2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis

Toshimitsu Niwa, Tomoyuki Katsuzaki, Shigeru Miyazaki, Tomoko Momoi, Takashi Akiba, Takashi Miyazaki, Kazuya Nokura, Fumitaka Hayase, Noriyuki Tatemichi, Yoshifumi Takei

Research output: Contribution to journalArticle

64 Citations (Scopus)

Fingerprint Dive into the research topics of 'Amyloid β<sub>2</sub>-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis'. Together they form a unique fingerprint.

Medicine & Life Sciences